SMS Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its facility - Unit-II, located at Plot No.24 & 24B and 36 & 37, S.V. Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad. This facility was inspected by USFDA in November 2017 and there were no ‘Form 483’ observations during the inspection.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.
